Skip to main content

Featured

In this interview, Oncology Data Advisor Editorial Board member Dr. Stephen Freedland, Professor of Urology at Cedars-Sinai Medical Center, speaks with Dr. Neeraj Agarwal, Director of the Genitourinary (GU) Medical Oncology Group at Huntsman Cancer Institute, about his recent publication of the TALAPRO-2 study. Dr. Agarwal delves into the results of the trial, which investigated the efficacy of talazoparib plus enzalutamide for first-line metastatic castration-resistant prostate cancer (mCRPC), and their practice-changing significance....

From the Editor's Desk

Oncology Data Advisor is excited to announce that Rahul Banerjee, MD, FACP, has been appointed the new Editor in Chief. Dr. Banerjee, an Assistant Professor of Medicine in the Division of Oncology at the University of Washington, Fred Hutchinson Cancer Center, has taken over the role from Thomas Abrams, MD, Assistant Professor of Medicine at Harvard Medical School, who has served in the role since 2021. They are both excited about the transition and have written brief outro and intro letter...